Chanan-Khan, A., Egyed, M., Robak, T., Martinelli de Oliveira, F. A., Echeveste, M. A., Dolan, S., . . . Gribben, J. G. (2017). Randomized phase 3 study of lenalidomide versus chlorambucil as first-line therapy for older patients with chronic lymphocytic leukemia (the ORIGIN trial). Leukemia.
シカゴスタイル引用形Chanan-Khan, A., et al. "Randomized Phase 3 Study of Lenalidomide Versus Chlorambucil As First-line Therapy for Older Patients With Chronic Lymphocytic Leukemia (the ORIGIN Trial)." Leukemia 2017.
MLA引用形式Chanan-Khan, A., et al. "Randomized Phase 3 Study of Lenalidomide Versus Chlorambucil As First-line Therapy for Older Patients With Chronic Lymphocytic Leukemia (the ORIGIN Trial)." Leukemia 2017.
警告: この引用は必ずしも正確ではありません.